Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.

Home
/
Records
/
Eir
/
Abbott Laboratories

EIR

•Abbott Laboratories•September 24, 2021

FDA EIR - Abbott Laboratories - September 24, 2021

View on Dashboard

Your cart

Your cart is empty.

Browse public document pages and click Buy this document. We'll ask for your email at checkout, no account needed up front.

Browse documents

Discuss this record with AI

ChatGPT

Claude

Perplexity

Grok

Record Details

This EIR record concerns Abbott Laboratories, with an inspection on September 24, 2021.

Company: Abbott Laboratories
Inspection Date: September 24, 2021
People: Scott T. Ballard
Joann M (Director)
Jolanna A. (Medical Content Writer)
Rob Stauffer
Eric S. Pittman ( Director, Bioresearch Monitoring Division (West) and FDA Delegate to the OECD Working Party on GLPs)

Open in Dashboard

ID · 5852760e-4717-4251-9e6f-60279ba8d184

Violation Codes2

FD&C Act 801(a)(3)21 CFR 16

Full citation text and observation details available on the Dashboard.

Global Key Solutions

Regulatory Data Transformed

Contact

New York Office:

370 Jay Street 7th Floor

Brooklyn, NY 11201

Scranton Office:

Scranton Enterprise Center, Suite 217

201 Lackawanna Avenue

Scranton, PA, 18503

🇺🇸+1 917-789-5099

🇪🇺+48 532-447-507

info@globalkeysolutions.net

Quick Links

KeyPedia™ Lite

Legal & Ethics

©2026, Global Key Solutions All rights reserved.

FDA EIR - Abbott Laboratories - September 24, 2021 | Global Key Solutions